Thyrocare net profit jumps 80% to Rs 48 crore in Q2, firm announces 2:1 bonus issue

Consolidated EBITDA rose 48 percent on-year, while EBITDA margin stood at 33 percent. "Thyrocare, India’s largest diagnostic test volume processor, processed 53.3 million tests in Q2FY26, marking a strong 21% year-on-year growth and reinforcing its leadership position in the diagnostics industry," the company said.

"The company continues to maintain a healthy balance sheet, remaining debt-free on a consolidated basis and holding net cash and short-term investments exceeding Rs 190 crore," it added.

Thyrocare Technologies bonus issue:

The company announced a bonus issue of shares in the ratio of 2:1. The record date to determine the eligibility of the shareholders set to receive the payment is yet to b announced.

A company announces bonus issue of shares to reward its existing shareholders with an investment opportunity, which is perceived to be attractive. While the issue of bonus shares increases the total number of shares issued and owned, it does not change the market capitalization of the company. This increases the overall liquidity of the stock, and makes it more affordable for other investors to add to their portfolio, creating strong upside potential for the stock.

The issuance of bonus shares will likely increase investors' confidence for the stock, as it reflects on the firm's strong financials and growth potential. Bonus issue essentially are free shares offered by a company from its reserves. Investors must own shares of the company as on the record date to be eligible for the bonus issue.

Thyrocare Technologies announces interim dividend:

The board of the company approved an interim dividend of Rs 7 per share for the financial year 2026. The record date to determine the eligibility of the shareholders set to receive the dividend has been set at October 24 (Friday).

The dividend will be paid within 30 days from the date of the board meeting.

What Thyrocare Technologies management said:

"We are pleased to report a robust set of results for the quarter and the announcement of our bonus issue on the occasion of 25 years of Thyrocare coinciding with the auspicious occasion of Diwali. These numbers underscore our continued focus on operational excellence, network expansion, and value-driven diagnostics. As we deepen our presence in underserved regions and scale our franchise and partner channels, we remain committed to delivering high-quality, affordable healthcare services across India," said Rahul Guha, MD & CEO of Thyrocare Technologies.

"We are delighted with Thyrocare's strong Q2FY26 performance, which reflects the strength of our business fundamentals, disciplined financial management, and the unwavering commitment of our teams. As we mark 25 years of trust and innovation, the bonus share announcement underscores our commitment to our shareholders and investors, and reinforces confidence in our long-term growth journey," said Alok Kumar Jagnani, Group CFO.

Thyrocare Technologies share price:

Thyrocare Technologies shares closed in the green with marginal gains on October 14. At close, the stock was up 0.24 percent to Rs 1,264.60 apiece. The stock’s P/E ratio currently stands at around 53.

The stock will be kept under active watch tomorrow what the market reopens.

Also read: Anand Rathi Wealth shares rally 13% after Q2 net profit rises 31% YoY to Rs 100 crore

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.